Investment
Features
FeesSafety
Academy
More
Pluang+

Compare NextEra Energy, Inc. (NEE) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance

NextEra Energy, Inc.Trade
Zimmer Biomet Holdings IncTrade

Price performance (Past 24H)

Key statistics

NextEra Energy, Inc. vs Zimmer Biomet Holdings Inc — how do they compare? NextEra Energy, Inc. trades at $82.99 (market cap $174.87B), while Zimmer Biomet Holdings Inc trades at $94.73 (market cap $17.97B). The key difference: NextEra Energy, Inc. is far larger — about 9.7× Zimmer Biomet Holdings Inc's market cap, and NextEra Energy, Inc. pays the higher dividend (2.97%). Which is the better fit depends on your goals.

NEEZBH
Market Cap
$174.87B$17.97B
Sector
UtilitiesHealth
52-Week High
$97.88$104.26
52-Week Low
$69.83$79.58
Enterprise Value
$282.20B$25.04B
Dividend Yield
2.97%1.02%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

NextEra Energy, Inc.

NextEra Energy (NEE) trades at $83.83, up 0.48% with a bearish technical signal despite strong analyst support. The company shows solid fundamentals with Q1 and Q2 2026 earnings beats, a 32.4% net income margin, and recent positive developments including a $1.9 billion DOE loan for nuclear plant restart. Cash flow improved to $1.6B net in 2025, though debt-to-asset ratio rose to 47.6%.

Outlook remains positive with 66.7% analyst buy ratings and a $100.20 consensus price target offering 19.5% upside. Key risks include rising leverage, competitive pressures, and execution of growth projects. The stock presents a growth opportunity in renewable energy with institutional backing, balanced by macroeconomic and regulatory uncertainties.

Zimmer Biomet Holdings Inc

Zimmer Biomet (ZBH) trades at $94.22, down 3.93% on the day, with a bearish technical signal but strong fundamentals including a 69.87% gross margin and three consecutive quarterly earnings beats. Revenue growth is steady, reaching $8.23B in 2025, though net income margin dipped to 8.56%. Recent leadership promotions aim to accelerate commercial transformation, while analyst consensus price target is $104.88, implying 11.3% upside.

The stock presents a value opportunity with a P/E of 22.87 and P/S of 2.17, supported by robust cash flow and dividend payments. Risks include rising debt-to-asset ratio (32.57% in 2025) and competitive pressures. Wall Street sentiment is mixed with 40.48% buy ratings, but technical indicators suggest near-term caution amid bearish moving averages.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About NextEra Energy, Inc.

NextEra Energy's regulated utility, Florida Power & Light, distributes power to more than 5 million customers in Florida. FP&L contributes more than 60% of the group's operating earnings. The renewable energy segment generates and sells power throughout the United States and Canada. Consolidated generation capacity totals more than 50 gigawatts and includes natural gas, nuclear, wind, and solar assets.

Read more on NEE

About Zimmer Biomet Holdings Inc

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.

Read more on ZBH